BioCentury’s roundup of translational innovations also includes a human hypothalamus atlas from Novo and collaborators, and four papers with links to newcos

BioCentury’s roundup of translational innovations

EMA agency issues positive opinions on Pylclari and Ztalmy, label expansions for Opdivo and Sogroya

Pharma gains rights to Oxbryta along with a sickle cell pipeline that could deliver $3B in peak sales

With one drug on the market and a second program entering pivotal trials, GBT has augmented its pipeline of treatments for sickle cell disease by in-licensing from Sanofi two research programs that

Global Blood's sickle cell candidate sets the stage for evaluating disease-modifying therapies using hemoglobin-based endpoints

Global Blood's sickle cell candidate sets the stage for evaluating disease-modifying therapies using hemoglobin-based endpoints